Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02713529
Title Safety Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Amgen
Indications
Therapies
Age Groups: adult
Covered Countries USA | ESP | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
Research Site Atlanta Georgia 30332 United States Details
Research Site Boston Massachusetts 02114 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Grand Rapids Michigan 49546 United States Details
Research Site New York New York 10021 United States Details
Research Site Philadelphia Pennsylvania 19111 United States Details
Research Site Greenville South Carolina 29605 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
Research Site Camperdown New South Wales 2050 Australia Details
Research Site Parkville Victoria 3050 Australia Details
Research Site Wilrijk 2610 Belgium Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Research Site Heidelberg 69120 Germany Details
Research Site Madrid 28040 Spain Details
Research Site Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field